Nanoparticle Rigidity for Brain Tumor Cell Uptake.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Nanoparticles (NPs) are widely used in biomedical applications, but their mechanical properties, particularly rigidity, are understudied.
• NP rigidity is increasingly recognized as a critical factor influencing cellular interactions and uptake in various biological contexts.

Purpose of the Study:

• To investigate the effect of nanoparticle rigidity on cellular uptake by brain glioma tumor cells.
• To understand how varying nanoparticle core stiffness influences interactions with glioblastoma cells for potential therapeutic delivery.

Main Methods:

• Synthesized nanoliposomes with poly(ethylene glycol) diacrylate (PEGDA) cores at different volume ratios (0, 10, 30 v/v%) to create varying rigidities.
• Characterized nanoparticle size and surface charge using Dynamic Light Scattering (DLS) and zeta potential measurements.
• Quantified cellular uptake in U87 glioblastoma cells using confocal microscopy and flow cytometry.

Main Results:

• All synthesized NPs exhibited similar size (106–132 nm) and surface charge (-2.0 to -3.0 mV).
• NPs with gel cores (10% and 30% PEGDA) demonstrated significantly higher cellular uptake (up to 9-fold) in U87 cells compared to NPs with aqueous cores.
• No significant difference in uptake was observed between NPs with 10% and 30% PEGDA cores, suggesting a threshold effect of rigidity.

Conclusions:

• Nanoparticle rigidity is a crucial parameter that can be tuned to enhance cellular uptake in glioblastoma.
• The findings provide valuable insights for designing more effective nanoparticle-based drug delivery systems for brain cancer.
• This research paves the way for developing targeted therapeutics by optimizing NP mechanical properties for glioma treatment.